Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“The Colorectal Cancer Alliance continues to lead the way in CRC science, patient care, and innovation. We were recently featured in the Pittsburgh Post-Gazette and dozens of media outlets nationwide in a story spotlighting a promising new combination therapy for CRC.
Our Chief Medical Consultant, John Marshall M.D., offered expert insight throughout the piece, reinforcing the Alliance’s role as a trusted voice in advancing evidence-based care. His perspective reflects what defines us: grounding hope in science and transforming breakthroughs into meaningful impact for patients and families.
And this week, we’re taking that mission even further.
Tomorrow at 2:30 p.m. ET, tune in to Curecast, a live broadcast introducing Project Cure CRC, our boldest effort yet to create a future free from colorectal cancer.
We’re thrilled to welcome Katie Couric as a special guest, alongside leading experts and inspiring advocates, for this defining moment.
Curecast is a call to action. The future of treatment is evolving, and the Alliance remains dedicated to leading with integrity, urgency, and unwavering focus to end this disease.
Read the full Post-Gazette article.
Join us live for Curecast on Nov. 6 at 2:30 p.m. ET.”
More posts featuring Michael Sapienza on OncoDaily.